Atrys Health, S.A. (FRA:A2T)

Market Cap	232.93M
Revenue (ttm)	226.24M
Net Income (ttm)	-24.59M
Shares Out	n/a
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	33.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,623
Open	2.570
Previous Close	2.690
Day's Range	2.570 - 2.750
52-Week Range	2.210 - 3.730
Beta	n/a
RSI	60.62
Earnings Date	Mar 28, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 2,045
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A2T

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.